volasertib Articles

Boehringer Ingelheim starts pivotal trial of volasertib in AML

1 March 2013

Boehringer Ingelheim will start Phase III trials of leukemia drug in 2013

12 December 2012

Analysts view Boehringer Ingelheim's first move into cancer drug market

11 October 2012

Showing 1-3 of 3 articles

Go to beginningPrevious
  • 1
NextGo to end